ArticleAnti-cancer agents in medicinal chemistry2025

The Mesoionic 1,3,4-thiadiazolium Derivative, MI-D, is a Potential Drug for Treating Glioblastoma by Impairing Mitochondrial Functions Linked to Energy Provision in Glioma Cells.

Marília Locatelli Corrêa-Ferreira et al.PubMed ↗Publisher ↗

No numbers read from the abstract.